Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOHN KNECHT

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1639360829
CMS profile
165485
Location
LEAGUE CITY, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$5,887.71

192 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $4,736.48 189
Consulting Fee $971.25 1
Education $179.98 2

By paying entity

PY2022 · entire year · sorted by reported total

Page 4 of 4; records 151–192 of 192 matching records. This page contains 42 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOHN KNECHT

NPI 1639360829 · CMS profile ID 165485

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

LEAGUE CITY, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–192 of 192 matching records. This page contains 42 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1639360829?year=2022&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOHN KNECHT, NPI 1639360829, CMS profile ID 165485. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–192 of 192 matching records. This page contains 42 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1639360829?year=2022&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). JOHN KNECHT, NPI 1639360829, CMS profile ID 165485. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–192 of 192 matching records. This page contains 42 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1639360829?year=2022&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
JOHN KNECHT, NPI 1639360829, CMS profile ID 165485, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–192 of 192 matching records. This page contains 42 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1639360829?year=2022&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

192 matching records · $5,887.71 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 192 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–192 of 192.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GlaxoSmithKline, LLC. $28.0203/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944513187 CMS
GlaxoSmithKline, LLC. $88.3303/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944513215 CMS
Novartis Pharmaceuticals Corporation $13.8203/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893845813 CMS
BeiGene USA, Inc. $2.8703/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940791855 CMS
Daiichi Sankyo Inc. $21.1203/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930812129 CMS
BeiGene USA, Inc. $22.5503/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940791857 CMS
Alexion Pharmaceuticals, Inc. $22.2603/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914923329 CMS
Gilead Sciences, Inc. $23.5203/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929608329 CMS
Rigel Pharmaceuticals, Inc. $15.6003/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962267761 CMS
Seagen Inc. $79.9903/09/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904098435 CMS
PFIZER INC. $25.2503/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949554941 CMS
Novartis Pharmaceuticals Corporation $9.0103/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893845805 CMS
GENZYME CORPORATION $15.2503/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939054077 CMS
GlaxoSmithKline, LLC. $22.2003/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944513195 CMS
Pharmacyclics LLC, an AbbVie Company $121.8403/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890342565 CMS
Takeda Pharmaceuticals U.S.A., Inc. $28.9403/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955687137 CMS
Novartis Pharmaceuticals Corporation $16.6903/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893845809 CMS
GlaxoSmithKline, LLC. $29.6902/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944513175 CMS
Incyte Corporation $18.7202/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943042073 CMS
Incyte Corporation $18.3802/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943042067 CMS
AstraZeneca Pharmaceuticals LP $23.3502/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914621047 CMS
Adaptive Biotechnologies Corporation $19.5402/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951430910 CMS
E.R. Squibb & Sons, L.L.C. $12.9902/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932861373 CMS
Taiho Oncology, Inc. $20.4502/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 924013151 CMS
Amgen Inc. $8.1602/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939410433 CMS
AstraZeneca Pharmaceuticals LP $16.7902/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914907865 CMS
Myovant Sciences Inc. $99.5102/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941217357 CMS
E.R. Squibb & Sons, L.L.C. $16.0001/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932861217 CMS
Amgen Inc. $5.0901/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939925167 CMS
Daiichi Sankyo Inc. $13.9601/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930807933 CMS
Novo Nordisk Inc $16.6801/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898733503 CMS
PFIZER INC. $21.6801/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949559415 CMS
Incyte Corporation $16.8101/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943042061 CMS
E.R. Squibb & Sons, L.L.C. $21.1001/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932861219 CMS
Dendreon Pharmaceuticals LLC $26.4501/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943102055 CMS
Kite Pharma, Inc. $13.3901/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920059493 CMS
Rigel Pharmaceuticals, Inc. $14.9501/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962267879 CMS
Daiichi Sankyo Inc. $20.7901/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930797065 CMS
Celgene Corporation $22.1001/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932861213 CMS
Incyte Corporation $21.6601/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943042063 CMS
E.R. Squibb & Sons, L.L.C. $10.3001/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932861215 CMS
AstraZeneca Pharmaceuticals LP $13.0401/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914700217 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $31,310.86 139
PY2020 $19,178.68 85
PY2021 $12,159.43 105
PY2022 $5,887.71 192
PY2023 $6,795.71 167
PY2024 $4,490.83 158
PY2025 $9,083.30 142

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $39,521.68 8
PY2024 Principal investigator $42,472.00 2
PY2023 Principal investigator $17,286.50 4
PY2022 Principal investigator $7,792.50 2
PY2021 Recipient $41,925.00 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $232.40 12/11/2025 Non-covered Recipient Entity
Tranquility Research
A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS No dispute reported 06/30/2026 1228717167
Principal investigator 1 PFIZER INC. $23,590.88 12/11/2025 Non-covered Recipient Entity
Tranquility Research
A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS No dispute reported 06/30/2026 1228717863
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $3,993.00 09/18/2025 Non-covered Recipient Entity
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233745192
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $3,000.00 08/26/2025 Non-covered Recipient Entity
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233745190
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $592.00 08/21/2025 Non-covered Recipient Entity
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233745186
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $3,750.00 08/21/2025 Non-covered Recipient Entity
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233745188
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $750.00 08/21/2025 Non-covered Recipient Entity
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233745194
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $3,613.40 07/16/2025 Non-covered Recipient Entity
TRANQUIL CLINICAL AND RESEARCH
Fruquintinib No dispute reported 06/30/2026 1223282728